Showing 1 - 10 of 18,613
innovation. This sentiment stems, in large part, from the belief that pharmaceutical research and development (R&D) entails …
Persistent link: https://www.econbiz.de/10014161723
The rise of blockbuster pharmaceutical acquisitions has prompted fears that unprecedented market concentration will weaken competition. Two of the most prominent concerns focus on the upstream and downstream ends of the pharmaceutical industry: (1) the concern that these mergers will concentrate...
Persistent link: https://www.econbiz.de/10011721586
pandemic; and more specifically for competition authorities, as demonstrated for example by the role innovation played in the … innovation debate, notably in the pharmaceutical industry, by giving an overview on firm and market-level incentives to carry out … research and development (R&D). Understanding these innovation incentives is relevant for a proper competition assessment where …
Persistent link: https://www.econbiz.de/10013227948
far behind the innovative manufacturing found in other industries. This lack of innovation in drug manufacturing stands in … stark contrast to the innovation present in drug discovery. Drug discovery is the focus of a calibrated innovation policy … dollars and in human lives. This article addresses the previously underappreciated role of manufacturing in innovation studies …
Persistent link: https://www.econbiz.de/10014038452
largely based on Open Innovation. For that purpose, exploratory case studies will be shown that exemplify the value of … implementing Open Innovation in the pandemic context. These case studies concern the pharmaceutical firm Pfizer, the biotechnology … systematic analysis of articles, scientific documents, and published reports related to the Open Innovation involvement of these …
Persistent link: https://www.econbiz.de/10014308369
We examine the role of spillover learning in shaping the value of exploratory versus incremental R&D. Using data from drug development, we show that novel drug candidates generate more knowledge spillovers than incremental ones. Despite being less likely to reach regulatory approval, they are...
Persistent link: https://www.econbiz.de/10014287391
Persistent link: https://www.econbiz.de/10011708133
Persistent link: https://www.econbiz.de/10012800211
Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making … innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is …
Persistent link: https://www.econbiz.de/10014136820
Persistent link: https://www.econbiz.de/10014448293